| Literature DB >> 34601346 |
Hanna C Gustafsson1, Anna S Young1, Gayle Stamos1, Sydney Wilken1, Natalie H Brito2, Moriah E Thomason3, Alice Graham1, Joel T Nigg1, Elinor L Sullivan4.
Abstract
In response to the COVID-19 pandemic, research institutions across the globe have modified their operations in ways that have limited or eliminated the amount of permissible in-person research interaction. In order to prevent the loss of important developmentally-timed data during the pandemic, researchers have quickly pivoted and developed innovative methods for remote assessment of research participants. In this manuscript, we describe methods developed for remote assessment of a parent child cohort with a focus on examining the perinatal environment, behavioral and biological indicators of child neurobehavioral development, parent-child interaction, as well as parent and child mental and physical health. We include recommendations relevant to adapting in-laboratory assessments for remote data collection and conclude with a description of the successful dissemination of the methods to eight research sites across the United States, each of whom are involved in Phase 1 of the HEALthy Brain and Child Development (HBCD) Study. These remote methods were born out of pandemic-related necessity; however, they have much wider applicability and may offer advantages over in-laboratory neurodevelopmental assessments.Entities:
Keywords: Biospecimens; COVID-19; HEALthy Brain and Child Development (HBCD) Study; Infant neurobehavior; Negative affect; Remote data collection methods
Mesh:
Year: 2021 PMID: 34601346 PMCID: PMC8483646 DOI: 10.1016/j.dcn.2021.101015
Source DB: PubMed Journal: Dev Cogn Neurosci ISSN: 1878-9293 Impact factor: 5.811
Feasibility of Modifying Infant Behavioral Measures.
| Task | Feasibility of Remote Adaption | Construct | Preliminary Quality Rating (% Useable) |
|---|---|---|---|
| Arm Restraint Procedure | 3 | Negative Valence | 94% |
| Still Face Paradigm | 3 | Negative Valence | 96% |
| Barrier Task | 1 | Negative Valence | – |
| Unpredictable Toy/Spider Task | 1 | Negative Valence | – |
| Stranger Approach | 0 | Negative Valence | – |
| Mother-Child Free Play | 3 | Social Processing, | 97% |
| Don't task | 3 | Social Processing, Cognitive Processes | 95% |
| Do task | 3 | Social Processing, Cognitive Processes | 95% |
| Strange Situation | 0 | Social Processing, Negative Valence | – |
| Object Permanence | 3 | Cognitive Processes | 98% |
| 3-D Object | 1 | Cognitive Processes | – |
| Visual A-not-B (Delayed Response) | 1 | Cognitive Processes | – |
| Detour Reaching | 1 | Cognitive Processes | – |
| Snack delay | 2 | Cognitive Processes | 99% |
| Visual Attention Task | 3 | Cognitive Processes | 94% |
*Scale for feasibly of remote adaption of the behavioral task: 0 = remote administration not possible, 1 = administration possible but not feasible, 2 = administration feasible with modification, 3 = minimal/no modification needed. Quality of ratings (the percentage of videos that were administered that were deemed usable) are reported on the subset of videos that have been assessed at OHSU and NYU at the time of this report (n = 348 for most tasks).
Fig. 1Example Images of Remote Behavioral Assessment. Prior to the remote visit participants are provided with example images. (A) The recommended positioning of the video enabled device for still face and arm restraint task which captures both a head-on view of the child and at least a profile view of the parent throughout the tasks. (B-C) Images of the still face paradigm. (D-E) Images of the arm restraint task. (F) The recommended positioning of the video enabled device relative to the parent-child dyad for the free-play task and (G) an example image of the free play task.
Remote Biospecimen Collection Methodologies.
| Biospecimen | Targets of Interest | Participant | Remote Collection Method | Transportation | Processing | Storage | % of Sent Samples Returned Usable |
|---|---|---|---|---|---|---|---|
| Blood (Plasma/Serum/Erythrocytes, White blood cells) | Nutriture, neurotoxicants, inflammation | Parent, Child (over 12 months of age) | Tasso | 4 °C | Centrifuge | -20 − -80 °C | 71% |
| Mitra | RT/4 °C | RT/4 °C | RT/4 °C | ||||
| DBS | RT | None | RT | ||||
| Urine | Drugs, EtOH, nicotine metabolites | Parent, Child | 4 °C | Aliquot | -20 − -80 °C | 78% | |
| Other Environmental Exposures | Parent, Child | 4 °C | Aliquot | -20 − -80 °C | |||
| Saliva | Genetics & epigenetics | Parent, Child | Oragene | RT | None | RT | 66% |
| Hormones, Inflammation | Parent, Child | Salimetrics | 4 °C | Aliquot | -20 − -80 °C | ||
| Finger/toe nails | Drugs, EtOH, nicotine metabolites | Parent, Child | RT | Weigh | RT | 65% | |
| Hair | Hormones, Drugs, EtOH, nicotine metabolites | Parent, Child (over 6 months of age) | RT | Weigh | RT, light-protected | 55% | |
| Stool | Microbiome | Parent, Child | Zymo Research DNA RNA collection kit | 4 °C or RT | None | -80 °C | 57% |
| Breastmilk | Inflammation, Nutriture, Drugs, Microbiome | Parent | 4 °C | Aliquot | -20 − -80 °C | 69% | |
| Deciduous Teeth | Nutriture & Neurotoxicants | Child (over 6 years of age) | RT | None | RT | – |
*DBS, dried blood spot; RT, room temperature; EtOH, ethanol; if not explicitly noted the biospecimen can be collected from the child at any age. The percentage of useable samples returned is reported for samples that were sent to participants from OHSU and NYU at the time of this report (n = 436), with the exception of urine, which was only reported for OHSU (n = 118 prenatal biospecimen kits). Notably, 76% of the participants (n=436) returned at least one sample. The samples described in the table met our initial quality criteria, which included arriving intact, with a sufficient volume, and in an insulated shipper that was still cold. Of note, few samples that were returned to our laboratories violated these quality criteria. Rather, most of the missing samples were ones where the participant did not return the biospecimen collection kit, or where a particular sample type was not relevant to them (e.g., not all women were still lactating at the time of the postnatal sample collection, and thus did not provide a breastmilk sample).
Fig. 2Blood Microsampling Techniques. Innovative methods for remote blood collection such as the Mitra Blood Collection Kit by Neoteryx (Torrance, CA, https://www.neoteryx.com/) (panels A-D) and Tasso SST OnDemand devices (Tasso, Inc., Seattle, WA, https://www.tassoinc.com/tasso-sst) (panels E-H) facilitate sampling of capillary blood from participants. (A) The Mitra™ volumetric absorbent microsampler is a polymer-based cartridge which absorbs a controlled volume of blood (up to 30 uls) of capillary blood from a finger-prick via a lancet. (B-C) The tip of the cartridge is dipped into the finger‐prick blood spot, and blood is adsorbed into the tip in a few seconds. (D) The tips are then air‐dried at room temperature. (E) The participant applies the Tasso SST OnDemand devices to their upper arm using a light adhesive. (F) The participant then presses a button that causes a vacuum to form and a lancet to prick the surface of the skin. (G) The vacuum draws blood out of the capillaries and into the sample collection tube attached to the bottom of the device. (H) The sample can then be centrifuged to obtain serum.